
Novo Nordisk CEO Agrees to Price Talks for Blockbuster Drugs Amid Senate Pressure
Novo Nordisk’s head, Lars Fruergaard Jørgensen, assured he would consider a reduction in the prices of its highly popular Ozempic and Wegovy for this growing U.S. concern over affordability. The discussion was led by Senator Bernie Sanders who called for a pricing decrease set par with the rest of the world. Lars Fruergaard Jørgensen, the…